According to The Australian Financial Review, shares in ASX minnow Micro-X Ltd surged 29 per cent after the Adelaide-based manufacturer said it secured two orders from south east Asian governments seeking to use its X-ray technology to help diagnose the coronavirus.
The company’s first product, the Carestream DRX Revolution Nano, is an ultra-lightweight digital medical X-ray system for the expanding mobile X-ray market in hospitals. Micro-X said production has moved to full capacity to fulfil all these orders within four weeks.
CEO Peter Rowland said chest X-rays are a key tool in monitoring the progression of the pneumonia-like symptoms of severe coronavirus infection.
While the normal early-stage diagnosis of coronavirus is by a blood test, like with pneumonia, a chest X-ray is used to detect fluid in the lungs, particularly with patients presenting with severe acute respiratory distress.
If you want to read this article in Japanese, please see the following link:
Subscribe to our English Newsletter